Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» fremanezumab
fremanezumab
Teva reports positive results for fremanezumab in phase IIIb migraine trial
Pharmaceutical Business Review
Tue, 12/18/18 - 10:14 am
Teva Pharmaceutical
migraines
clinical trials
fremanezumab
Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
Sat, 09/1/18 - 03:38 pm
biotech
FDA
Roche
Tecentriq
GSK
mepolizumab
Teva Pharmaceutical
fremanezumab
Adamis Pharmaceuticals
Symjepi
Insmed
ALIS
Antares
XYOSTED
Eli Lilly
galcanezumab
Pfizer
dacomitinib
Teva confident migraine drug will launch this year despite new manufacturing woes
Biopharma Dive
Tue, 08/7/18 - 08:45 pm
Teva Pharmaceutical
fremanezumab
migraines
Teva to Discontinue Trial of Fremanezumab in Chronic Cluster Headache
CP Wire
Fri, 06/15/18 - 09:16 am
Teva Pharmaceutical
fremanezumab
cluster headaches
migraines
Teva to Discontinue Trial of Fremanezumab in Chronic Cluster Headache
Fri, 06/15/18 - 08:58 am
Teva
fremanezumab
cluster headaches
Teva Confirms September PDUFA Date for Fremanezumab
CP Wire
Wed, 05/23/18 - 09:47 am
Teva
fremanezumab
migraine
episodic migraines
FDA
Teva Confirms September PDUFA Date for Fremanezumab
Wed, 05/23/18 - 09:17 am
Teva
fremanezumab
migraine
episodic migraines
Migraine drug delay would compound Teva's troubles
Reuters
Thu, 05/3/18 - 11:05 pm
Teva Pharmaceutical
migraines
fremanezumab
Will Teva's Fremanezumab Be Delayed due to Troubles at Celltrion?
Market Realist
Mon, 03/26/18 - 09:43 am
Teva Pharmaceutical
fremanezumab
Celltrion
migraines
Teva's Turnarond: Is It Ever Or Never?
Forbes
Thu, 02/8/18 - 11:53 pm
Teva Pharmaceutical
Copaxone
migraines
fremanezumab
In latest blow to Teva, CGRP migraine med delayed while rivals race towards the finish line
Endpoints
Thu, 02/8/18 - 09:40 am
Teva Pharmaceutical
migraines
CGRP blockers
fremanezumab
Teva's new launches won't feel the sting of hefty cost cuts: CEO
Fierce Pharma
Mon, 12/18/17 - 11:25 am
Teva Pharmaceutical
drug launches
Pharma CEOs
Kåre Schultz
layoffs
Austedo
fremanezumab
Teva posts positive phase 3 migraine data, plots FDA submission
Fierce Biotech
Wed, 05/31/17 - 11:02 am
Teva Pharmaceutical
migraines
FDA
clinical trials
fremanezumab